CompletedNCT06164756
Long-term follow-up after ketamine treatment for Parkinson’s
About this title
Read the official source — NCT06164756Observational studyAges 40–80United StatesDepression
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 40 years to 80 years. Other eligibility criteria applied.
- Listed locations
- New HavenSee all locations and recruitment
Study information
Study start dateStarted: October 18, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 49
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Other
- Locations
- United States
- Age range
- From 40 Years to 80 Years
- Official registry ID
- NCT06164756
- Official title
Show the full official title
Long-Term Follow-Up for Subjects Enrolled in the Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD) Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Who was this study for?
This study was for people with depression. Listed age limits: 40 years to 80 years. Other eligibility criteria applied.
